I do think that is important to have but, I mean, it is always going to be individual case too, though, obviously.

If we are going to have a comprehensive discussion about how to promote innovation and medical advancements, we can't simply focus on the FDA.

We all agree that the Federal Government and Congress can play a role to help accelerate the discovery, development and delivery of promising new treatments to patients.

I would encourage them to do what they can to support that.

I look forward to working with my colleagues in a bipartisan way to ensure that promising new medicines get to patients in a timely manner, and they are safe and effective.

the purpose of the breakthrough therapy designation was to, as you say, Mr. Pallone, too, advance and give the flexibility for FDA to respond to the current state of science

I ask the Republican leadership to bring up the bill that would extend critical unemployment insurance. So far, the gentleman from Ohio, Speaker Boehner, is telling struggling Americans that they are out of luck and out of money. This bill…

As ranking member of this subcommittee and a member of the Communications and Internet Subcommittee, telehealth has been an interest of mine for some time.

I strongly believe as policymakers we need to be actively working to leverage technology to lower costs, increase access, and improve quality of care.

Ranking Member Pallone and I will be releasing a call for ideas following the hearing.

It is important for people like you to speak out about when the healthcare system works for them and when it doesn't.

This outdated language says that patients can only receive care if they are in a rural area presenting from a clinical site.